日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The antitumor mechanism of oclacitinib in canine lymphoma

奥克拉替尼在犬淋巴瘤中的抗肿瘤机制

Harada, Miruki; Inanaga, Sakuya; Sakurai, Masashi; Shibutani, Shusaku; Sugasawa, Takehito; Murayama, Nobuo; Osumi, Takafumi; Baba, Yuta; Sakai, Hiroki; Maeda, Sadatoshi; Igase, Masaya; Mizuno, Takuya

Intestinal and esophageal microbiota in esophageal cancer development and treatment

肠道和食管微生物群在食管癌发生发展及治疗中的作用

Baba, Yuta; Tajima, Kohei; Yoshimura, Kiyoshi

Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors

韦荣氏球菌和链球菌与肠道菌群老化有关,并影响免疫检查点抑制剂的疗效。

Hirasawa, Yuya; Isobe, Junya; Hosonuma, Masahiro; Tsurui, Toshiaki; Baba, Yuta; Funayama, Eiji; Tajima, Kohei; Murayama, Masakazu; Narikawa, Yoichiro; Toyoda, Hitoshi; Shida, Midori; Sasaki, Aya; Maruyama, Yuuki; Amari, Yasunobu; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Sambe, Takehiko; Uchida, Naoki; Wada, Satoshi; Kobayashi, Shinichi; Kiuchi, Yuji; Kuramasu, Atsuo; Yoshimura, Kiyoshi; Tsunoda, Takuya

Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity

肌苷可调控PD-1阻断反应,并与PD-1/CTLA-4双重免疫疗法产生协同作用,从而增强抗肿瘤免疫力。

Narikawa, Yoichiro; Kuramasu, Atsuo; Hosonuma, Masahiro; Murayama, Masakazu; Funayama, Eiji; Sasaki, Akiko; Baba, Yuta; Toyoda, Hitoshi; Isobe, Junya; Tajima, Kohei; Nakashima, Rie; Sasaki, Aya; Maruyama, Yuki; Yamazaki, Yoshitaka; Shida, Midori; Tsurui, Toshiaki; Hirasawa, Yuya; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Horiike, Atsushi; Kobayashi, Shinichi; Tsunoda, Takuya; Kobayashi, Sei; Kobayashi, Hitome; Oguchi, Tatsunori; Shimane, Toshikazu; Kiuchi, Yuji; Yoshimura, Kiyoshi

Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8(+) T cells as a predictor of clinical benefit

Ki-67在抗程序性细胞死亡蛋白-1抗体结合的CD8(+) T细胞中的表达可作为临床获益的预测指标

Tsurui, Toshiaki; Hosonuma, Masahiro; Sasaki, Aya; Maruyama, Yuuki; Amari, Yasunobu; Funayama, Eiji; Tajima, Kohei; Toyoda, Hitoshi; Isobe, Junya; Yamazaki, Yoshitaka; Baba, Yuta; Shida, Midori; Udaka, Yuko; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Wada, Satoshi; Kuramasu, Atsuo; Tsuji, Mayumi; Kiuchi, Yuji; Tsunoda, Takuya; Yoshimura, Kiyoshi

Efficacy of video-otoscope-guided septum bulla fenestration and middle ear lavage for treating otitis media in cats

视频耳镜引导下鼻中隔泡开窗术和中耳冲洗治疗猫中耳炎的疗效

Osumi, Takafumi; Onishi, Ikki; Baba, Yuta

Acute Myeloid Leukemia with MYC Amplification on a Ring Chromosome 8

环状染色体 8 上 MYC 扩增的急性髓系白血病

Baba, Yuta; Sakai, Hirotaka; Maeda, Nodoka; Abe, Maasa; Kabasawa, Nobuyuki; Fukuda, Tetsuya

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer

丁酸单胞菌是预测食管癌术后复发的关键肠道菌群组成部分

Otsuka, Koji; Isobe, Junya; Asai, Yoshiyuki; Nakano, Tomohisa; Hattori, Kouya; Ariyoshi, Tomotake; Yamashita, Takeshi; Motegi, Kentaro; Saito, Akira; Kohmoto, Masahiro; Hosonuma, Masahiro; Kuramasu, Atsuo; Baba, Yuta; Murayama, Masakazu; Narikawa, Yoichiro; Toyoda, Hitoshi; Funayama, Eiji; Tajima, Kohei; Shida, Midori; Hirasawa, Yuya; Tsurui, Toshiaki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Kiuchi, Yuji; Kobayashi, Shinichi; Horiike, Atsushi; Goto, Satoru; Murakami, Masahiko; Kim, Yun-Gi; Tsunoda, Takuya; Yoshimura, Kiyoshi

Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit

效应调节性T细胞上纳武利尤单抗受体的占有率可预测临床获益

Hosonuma, Masahiro; Hirasawa, Yuya; Kuramasu, Atsuo; Murayama, Masakazu; Narikawa, Yoichiro; Toyoda, Hitoshi; Baba, Yuta; Isobe, Junya; Funayama, Eiji; Tajima, Kohei; Shida, Midori; Hamada, Kazuyuki; Tsurui, Toshiaki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Horiike, Atsushi; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Kiuchi, Yuji; Kobayashi, Shinichi; Tsunoda, Takuya; Yoshimura, Kiyoshi

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

异丁酸可增强抗PD-1抗体的抗肿瘤作用

Murayama, Masakazu; Hosonuma, Masahiro; Kuramasu, Atsuo; Kobayashi, Sei; Sasaki, Akiko; Baba, Yuta; Narikawa, Yoichiro; Toyoda, Hitoshi; Isobe, Junya; Funayama, Eiji; Tajima, Kohei; Sasaki, Aya; Maruyama, Yuki; Yamazaki, Yoshitaka; Shida, Midori; Hamada, Kazuyuki; Hirasawa, Yuya; Tsurui, Toshiaki; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Horiike, Atsushi; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Kobayashi, Shinichi; Shimane, Toshikazu; Tsunoda, Takuya; Kobayashi, Hitome; Kiuchi, Yuji; Yoshimura, Kiyoshi